Breast cancer survivors with excess body weight at increased risk of developing second cancer

Breast cancer survivors who are overweight have a statistically significant increased risk of developing second primary cancers, according to results from a study conducted by Kaiser Permanente researchers and published in the Journal of the National Cancer Institute. There are approximately 3.9 million breast cancer survivors in the United States today and studies have found women diagnosed with breast cancer […]

Read more

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors […]

Read more

Newly identified biomarker could predict response to immune checkpoint inhibitors

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other […]

Read more

Precision medicine helping more people survive blood cancers: report

The Canadian Cancer Society estimates that around 21,000 Canadians will be diagnosed with blood cancers in 2019 — representing about 10 per cent of all cancers. Related Cancer now the number one killer in wealthy countries: study More women may need breast cancer gene test: U.S. guidelines And those Canadians stand a better chance today than they did 30 years […]

Read more

Metmorfin with syrosingopine destroy cancer

“Cocktail” of well known doctors drugs metmorfin and syrosingopine able to destroy cancer – this assumption has already been expressed by scientists before, found confirmation in the new study, researchers from the Basel University. According to scientific experts, a combination of metmorfin with syrosingopine block energy production in cancer cells, bringing them to self-destruct. Old drugs are often studied to […]

Read more

Sugar mannose protects against cancer

Sugar mannose is known as a substitute for glucose.Scientific specialists of the Institute of cancer research in the UK concluded that mannose can protect the body against the development of obesity, also can stop the progression of the cancer, as it increased the influence on tumor chemotherapy. About this work of scientists told the journal Nature. During the experiments, mannose […]

Read more